Product Code:214775
Published Date: Jan 13,2022
Pages: 105
Region: Global
Category: Pharma & Healthcare
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
SELECT A FORMAT
ADD TO BASKET
BUY NOW
Provide comprehensive and accurate analysis and reports according to your exact requirements
As the global economy mends, the 2021 growth of Ocular Drug Delivery will have significant change from previous year. According to our (LP Information) latest study, the global Ocular Drug Delivery market size is USD million in 2022 from USD 24130 million in 2021, with a change of % between 2021 and 2022. The global Ocular Drug Delivery market size will reach USD 33910 million in 2028, growing at a CAGR of 5.0% over the analysis period. The United States Ocular Drug Delivery market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Ocular Drug Delivery market, reaching US$ million by the year 2028. As for the Europe Ocular Drug Delivery landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period. Global main Ocular Drug Delivery players cover OCULAR THERAPEUTIX, INC, Alimera Sciences, Allergan, Plc, and EyeGate Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021. This report presents a comprehensive overview, market shares, and growth opportunities of Ocular Drug Delivery market by product type, application, key manufacturers and key regions and countries. Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6 Ocular Insert Iontophoresis Intraocular Implants In Situ Gel & Punctal Plugs Others Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7. Hospitals Ambulatory Surgical Centers Ophthalmic Clinics Homecare Settings This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include OCULAR THERAPEUTIX, INC Alimera Sciences Allergan, Plc EyeGate Pharma Valeant Pharmaceuticals International, Inc Envisia Therapeutics Clearside Biomedical Graybug Vision Inc Taiwan Liposome Company Santen Pharmaceutical
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ocular Drug Delivery Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Ocular Drug Delivery by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Ocular Drug Delivery by Country/Region, 2017, 2022 & 2028
2.2 Ocular Drug Delivery Segment by Type
2.2.1 Ocular Insert
2.2.2 Iontophoresis
2.2.3 Intraocular Implants
2.2.4 In Situ Gel & Punctal Plugs
2.2.5 Others
2.3 Ocular Drug Delivery Sales by Type
2.3.1 Global Ocular Drug Delivery Sales Market Share by Type (2017-2022)
2.3.2 Global Ocular Drug Delivery Revenue and Market Share by Type (2017-2022)
2.3.3 Global Ocular Drug Delivery Sale Price by Type (2017-2022)
2.4 Ocular Drug Delivery Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgical Centers
2.4.3 Ophthalmic Clinics
2.4.4 Homecare Settings
2.5 Ocular Drug Delivery Sales by Application
2.5.1 Global Ocular Drug Delivery Sale Market Share by Application (2017-2022)
2.5.2 Global Ocular Drug Delivery Revenue and Market Share by Application (2017-2022)
2.5.3 Global Ocular Drug Delivery Sale Price by Application (2017-2022)
3 Global Ocular Drug Delivery by Company
3.1 Global Ocular Drug Delivery Breakdown Data by Company
3.1.1 Global Ocular Drug Delivery Annual Sales by Company (2020-2022)
3.1.2 Global Ocular Drug Delivery Sales Market Share by Company (2020-2022)
3.2 Global Ocular Drug Delivery Annual Revenue by Company (2020-2022)
3.2.1 Global Ocular Drug Delivery Revenue by Company (2020-2022)
3.2.2 Global Ocular Drug Delivery Revenue Market Share by Company (2020-2022)
3.3 Global Ocular Drug Delivery Sale Price by Company
3.4 Key Manufacturers Ocular Drug Delivery Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ocular Drug Delivery Product Location Distribution
3.4.2 Players Ocular Drug Delivery Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Ocular Drug Delivery by Geographic Region
4.1 World Historic Ocular Drug Delivery Market Size by Geographic Region (2017-2022)
4.1.1 Global Ocular Drug Delivery Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Ocular Drug Delivery Annual Revenue by Geographic Region
4.2 World Historic Ocular Drug Delivery Market Size by Country/Region (2017-2022)
4.2.1 Global Ocular Drug Delivery Annual Sales by Country/Region (2017-2022)
4.2.2 Global Ocular Drug Delivery Annual Revenue by Country/Region
4.3 Americas Ocular Drug Delivery Sales Growth
4.4 APAC Ocular Drug Delivery Sales Growth
4.5 Europe Ocular Drug Delivery Sales Growth
4.6 Middle East & Africa Ocular Drug Delivery Sales Growth
5 Americas
5.1 Americas Ocular Drug Delivery Sales by Country
5.1.1 Americas Ocular Drug Delivery Sales by Country (2017-2022)
5.1.2 Americas Ocular Drug Delivery Revenue by Country (2017-2022)
5.2 Americas Ocular Drug Delivery Sales by Type
5.3 Americas Ocular Drug Delivery Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ocular Drug Delivery Sales by Region
6.1.1 APAC Ocular Drug Delivery Sales by Region (2017-2022)
6.1.2 APAC Ocular Drug Delivery Revenue by Region (2017-2022)
6.2 APAC Ocular Drug Delivery Sales by Type
6.3 APAC Ocular Drug Delivery Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Ocular Drug Delivery by Country
7.1.1 Europe Ocular Drug Delivery Sales by Country (2017-2022)
7.1.2 Europe Ocular Drug Delivery Revenue by Country (2017-2022)
7.2 Europe Ocular Drug Delivery Sales by Type
7.3 Europe Ocular Drug Delivery Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ocular Drug Delivery by Country
8.1.1 Middle East & Africa Ocular Drug Delivery Sales by Country (2017-2022)
8.1.2 Middle East & Africa Ocular Drug Delivery Revenue by Country (2017-2022)
8.2 Middle East & Africa Ocular Drug Delivery Sales by Type
8.3 Middle East & Africa Ocular Drug Delivery Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ocular Drug Delivery
10.3 Manufacturing Process Analysis of Ocular Drug Delivery
10.4 Industry Chain Structure of Ocular Drug Delivery
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ocular Drug Delivery Distributors
11.3 Ocular Drug Delivery Customer
12 World Forecast Review for Ocular Drug Delivery by Geographic Region
12.1 Global Ocular Drug Delivery Market Size Forecast by Region
12.1.1 Global Ocular Drug Delivery Forecast by Region (2023-2028)
12.1.2 Global Ocular Drug Delivery Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ocular Drug Delivery Forecast by Type
12.7 Global Ocular Drug Delivery Forecast by Application
13 Key Players Analysis
13.1 OCULAR THERAPEUTIX, INC
13.1.1 OCULAR THERAPEUTIX, INC Company Information
13.1.2 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Product Offered
13.1.3 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 OCULAR THERAPEUTIX, INC Main Business Overview
13.1.5 OCULAR THERAPEUTIX, INC Latest Developments
13.2 Alimera Sciences
13.2.1 Alimera Sciences Company Information
13.2.2 Alimera Sciences Ocular Drug Delivery Product Offered
13.2.3 Alimera Sciences Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Alimera Sciences Main Business Overview
13.2.5 Alimera Sciences Latest Developments
13.3 Allergan, Plc
13.3.1 Allergan, Plc Company Information
13.3.2 Allergan, Plc Ocular Drug Delivery Product Offered
13.3.3 Allergan, Plc Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Allergan, Plc Main Business Overview
13.3.5 Allergan, Plc Latest Developments
13.4 EyeGate Pharma
13.4.1 EyeGate Pharma Company Information
13.4.2 EyeGate Pharma Ocular Drug Delivery Product Offered
13.4.3 EyeGate Pharma Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 EyeGate Pharma Main Business Overview
13.4.5 EyeGate Pharma Latest Developments
13.5 Valeant Pharmaceuticals International, Inc
13.5.1 Valeant Pharmaceuticals International, Inc Company Information
13.5.2 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Product Offered
13.5.3 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Valeant Pharmaceuticals International, Inc Main Business Overview
13.5.5 Valeant Pharmaceuticals International, Inc Latest Developments
13.6 Envisia Therapeutics
13.6.1 Envisia Therapeutics Company Information
13.6.2 Envisia Therapeutics Ocular Drug Delivery Product Offered
13.6.3 Envisia Therapeutics Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Envisia Therapeutics Main Business Overview
13.6.5 Envisia Therapeutics Latest Developments
13.7 Clearside Biomedical
13.7.1 Clearside Biomedical Company Information
13.7.2 Clearside Biomedical Ocular Drug Delivery Product Offered
13.7.3 Clearside Biomedical Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Clearside Biomedical Main Business Overview
13.7.5 Clearside Biomedical Latest Developments
13.8 Graybug Vision Inc
13.8.1 Graybug Vision Inc Company Information
13.8.2 Graybug Vision Inc Ocular Drug Delivery Product Offered
13.8.3 Graybug Vision Inc Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Graybug Vision Inc Main Business Overview
13.8.5 Graybug Vision Inc Latest Developments
13.9 Taiwan Liposome Company
13.9.1 Taiwan Liposome Company Company Information
13.9.2 Taiwan Liposome Company Ocular Drug Delivery Product Offered
13.9.3 Taiwan Liposome Company Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Taiwan Liposome Company Main Business Overview
13.9.5 Taiwan Liposome Company Latest Developments
13.10 Santen Pharmaceutical
13.10.1 Santen Pharmaceutical Company Information
13.10.2 Santen Pharmaceutical Ocular Drug Delivery Product Offered
13.10.3 Santen Pharmaceutical Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Santen Pharmaceutical Main Business Overview
13.10.5 Santen Pharmaceutical Latest Developments
14 Research Findings and Conclusion
List of Tables Table 1. Ocular Drug Delivery Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions) Table 2. Ocular Drug Delivery Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions) Table 3. Major Players of Ocular Insert Table 4. Major Players of Iontophoresis Table 5. Major Players of Intraocular Implants Table 6. Major Players of In Situ Gel & Punctal Plugs Table 7. Major Players of Others Table 8. Global Ocular Drug Delivery Sales by Type (2017-2022) & (K Doses) Table 9. Global Ocular Drug Delivery Sales Market Share by Type (2017-2022) Table 10. Global Ocular Drug Delivery Revenue by Type (2017-2022) & ($ million) Table 11. Global Ocular Drug Delivery Revenue Market Share by Type (2017-2022) Table 12. Global Ocular Drug Delivery Sale Price by Type (2017-2022) & (USD/Dose) Table 13. Global Ocular Drug Delivery Sales by Application (2017-2022) & (K Doses) Table 14. Global Ocular Drug Delivery Sales Market Share by Application (2017-2022) Table 15. Global Ocular Drug Delivery Revenue by Application (2017-2022) Table 16. Global Ocular Drug Delivery Revenue Market Share by Application (2017-2022) Table 17. Global Ocular Drug Delivery Sale Price by Application (2017-2022) & (USD/Dose) Table 18. Global Ocular Drug Delivery Sales by Company (2020-2022) & (K Doses) Table 19. Global Ocular Drug Delivery Sales Market Share by Company (2020-2022) Table 20. Global Ocular Drug Delivery Revenue by Company (2020-2022) ($ Millions) Table 21. Global Ocular Drug Delivery Revenue Market Share by Company (2020-2022) Table 22. Global Ocular Drug Delivery Sale Price by Company (2020-2022) & (USD/Dose) Table 23. Key Manufacturers Ocular Drug Delivery Producing Area Distribution and Sales Area Table 24. Players Ocular Drug Delivery Products Offered Table 25. Ocular Drug Delivery Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) Table 26. New Products and Potential Entrants Table 27. Mergers & Acquisitions, Expansion Table 28. Global Ocular Drug Delivery Sales by Geographic Region (2017-2022) & (K Doses) Table 29. Global Ocular Drug Delivery Sales Market Share Geographic Region (2017-2022) Table 30. Global Ocular Drug Delivery Revenue by Geographic Region (2017-2022) & ($ millions) Table 31. Global Ocular Drug Delivery Revenue Market Share by Geographic Region (2017-2022) Table 32. Global Ocular Drug Delivery Sales by Country/Region (2017-2022) & (K Doses) Table 33. Global Ocular Drug Delivery Sales Market Share by Country/Region (2017-2022) Table 34. Global Ocular Drug Delivery Revenue by Country/Region (2017-2022) & ($ millions) Table 35. Global Ocular Drug Delivery Revenue Market Share by Country/Region (2017-2022) Table 36. Americas Ocular Drug Delivery Sales by Country (2017-2022) & (K Doses) Table 37. Americas Ocular Drug Delivery Sales Market Share by Country (2017-2022) Table 38. Americas Ocular Drug Delivery Revenue by Country (2017-2022) & ($ Millions) Table 39. Americas Ocular Drug Delivery Revenue Market Share by Country (2017-2022) Table 40. Americas Ocular Drug Delivery Sales by Type (2017-2022) & (K Doses) Table 41. Americas Ocular Drug Delivery Sales Market Share by Type (2017-2022) Table 42. Americas Ocular Drug Delivery Sales by Application (2017-2022) & (K Doses) Table 43. Americas Ocular Drug Delivery Sales Market Share by Application (2017-2022) Table 44. APAC Ocular Drug Delivery Sales by Region (2017-2022) & (K Doses) Table 45. APAC Ocular Drug Delivery Sales Market Share by Region (2017-2022) Table 46. APAC Ocular Drug Delivery Revenue by Region (2017-2022) & ($ Millions) Table 47. APAC Ocular Drug Delivery Revenue Market Share by Region (2017-2022) Table 48. APAC Ocular Drug Delivery Sales by Type (2017-2022) & (K Doses) Table 49. APAC Ocular Drug Delivery Sales Market Share by Type (2017-2022) Table 50. APAC Ocular Drug Delivery Sales by Application (2017-2022) & (K Doses) Table 51. APAC Ocular Drug Delivery Sales Market Share by Application (2017-2022) Table 52. Europe Ocular Drug Delivery Sales by Country (2017-2022) & (K Doses) Table 53. Europe Ocular Drug Delivery Sales Market Share by Country (2017-2022) Table 54. Europe Ocular Drug Delivery Revenue by Country (2017-2022) & ($ Millions) Table 55. Europe Ocular Drug Delivery Revenue Market Share by Country (2017-2022) Table 56. Europe Ocular Drug Delivery Sales by Type (2017-2022) & (K Doses) Table 57. Europe Ocular Drug Delivery Sales Market Share by Type (2017-2022) Table 58. Europe Ocular Drug Delivery Sales by Application (2017-2022) & (K Doses) Table 59. Europe Ocular Drug Delivery Sales Market Share by Application (2017-2022) Table 60. Middle East & Africa Ocular Drug Delivery Sales by Country (2017-2022) & (K Doses) Table 61. Middle East & Africa Ocular Drug Delivery Sales Market Share by Country (2017-2022) Table 62. Middle East & Africa Ocular Drug Delivery Revenue by Country (2017-2022) & ($ Millions) Table 63. Middle East & Africa Ocular Drug Delivery Revenue Market Share by Country (2017-2022) Table 64. Middle East & Africa Ocular Drug Delivery Sales by Type (2017-2022) & (K Doses) Table 65. Middle East & Africa Ocular Drug Delivery Sales Market Share by Type (2017-2022) Table 66. Middle East & Africa Ocular Drug Delivery Sales by Application (2017-2022) & (K Doses) Table 67. Middle East & Africa Ocular Drug Delivery Sales Market Share by Application (2017-2022) Table 68. Key Market Drivers & Growth Opportunities of Ocular Drug Delivery Table 69. Key Market Challenges & Risks of Ocular Drug Delivery Table 70. Key Industry Trends of Ocular Drug Delivery Table 71. Ocular Drug Delivery Raw Material Table 72. Key Suppliers of Raw Materials Table 73. Ocular Drug Delivery Distributors List Table 74. Ocular Drug Delivery Customer List Table 75. Global Ocular Drug Delivery Sales Forecast by Region (2023-2028) & (K Doses) Table 76. Global Ocular Drug Delivery Sales Market Forecast by Region Table 77. Global Ocular Drug Delivery Revenue Forecast by Region (2023-2028) & ($ millions) Table 78. Global Ocular Drug Delivery Revenue Market Share Forecast by Region (2023-2028) Table 79. Americas Ocular Drug Delivery Sales Forecast by Country (2023-2028) & (K Doses) Table 80. Americas Ocular Drug Delivery Revenue Forecast by Country (2023-2028) & ($ millions) Table 81. APAC Ocular Drug Delivery Sales Forecast by Region (2023-2028) & (K Doses) Table 82. APAC Ocular Drug Delivery Revenue Forecast by Region (2023-2028) & ($ millions) Table 83. Europe Ocular Drug Delivery Sales Forecast by Country (2023-2028) & (K Doses) Table 84. Europe Ocular Drug Delivery Revenue Forecast by Country (2023-2028) & ($ millions) Table 85. Middle East & Africa Ocular Drug Delivery Sales Forecast by Country (2023-2028) & (K Doses) Table 86. Middle East & Africa Ocular Drug Delivery Revenue Forecast by Country (2023-2028) & ($ millions) Table 87. Global Ocular Drug Delivery Sales Forecast by Type (2023-2028) & (K Doses) Table 88. Global Ocular Drug Delivery Sales Market Share Forecast by Type (2023-2028) Table 89. Global Ocular Drug Delivery Revenue Forecast by Type (2023-2028) & ($ Millions) Table 90. Global Ocular Drug Delivery Revenue Market Share Forecast by Type (2023-2028) Table 91. Global Ocular Drug Delivery Sales Forecast by Application (2023-2028) & (K Doses) Table 92. Global Ocular Drug Delivery Sales Market Share Forecast by Application (2023-2028) Table 93. Global Ocular Drug Delivery Revenue Forecast by Application (2023-2028) & ($ Millions) Table 94. Global Ocular Drug Delivery Revenue Market Share Forecast by Application (2023-2028) Table 95. OCULAR THERAPEUTIX, INC Basic Information, Ocular Drug Delivery Manufacturing Base, Sales Area and Its Competitors Table 96. OCULAR THERAPEUTIX, INC Ocular Drug Delivery Product Offered Table 97. OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022) Table 98. OCULAR THERAPEUTIX, INC Main Business Table 99. OCULAR THERAPEUTIX, INC Latest Developments Table 100. Alimera Sciences Basic Information, Ocular Drug Delivery Manufacturing Base, Sales Area and Its Competitors Table 101. Alimera Sciences Ocular Drug Delivery Product Offered Table 102. Alimera Sciences Ocular Drug Delivery Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022) Table 103. Alimera Sciences Main Business Table 104. Alimera Sciences Latest Developments Table 105. Allergan, Plc Basic Information, Ocular Drug Delivery Manufacturing Base, Sales Area and Its Competitors Table 106. Allergan, Plc Ocular Drug Delivery Product Offered Table 107. Allergan, Plc Ocular Drug Delivery Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022) Table 108. Allergan, Plc Main Business Table 109. Allergan, Plc Latest Developments Table 110. EyeGate Pharma Basic Information, Ocular Drug Delivery Manufacturing Base, Sales Area and Its Competitors Table 111. EyeGate Pharma Ocular Drug Delivery Product Offered Table 112. EyeGate Pharma Ocular Drug Delivery Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022) Table 113. EyeGate Pharma Main Business Table 114. EyeGate Pharma Latest Developments Table 115. Valeant Pharmaceuticals International, Inc Basic Information, Ocular Drug Delivery Manufacturing Base, Sales Area and Its Competitors Table 116. Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Product Offered Table 117. Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022) Table 118. Valeant Pharmaceuticals International, Inc Main Business Table 119. Valeant Pharmaceuticals International, Inc Latest Developments Table 120. Envisia Therapeutics Basic Information, Ocular Drug Delivery Manufacturing Base, Sales Area and Its Competitors Table 121. Envisia Therapeutics Ocular Drug Delivery Product Offered Table 122. Envisia Therapeutics Ocular Drug Delivery Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022) Table 123. Envisia Therapeutics Main Business Table 124. Envisia Therapeutics Latest Developments Table 125. Clearside Biomedical Basic Information, Ocular Drug Delivery Manufacturing Base, Sales Area and Its Competitors Table 126. Clearside Biomedical Ocular Drug Delivery Product Offered Table 127. Clearside Biomedical Ocular Drug Delivery Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022) Table 128. Clearside Biomedical Main Business Table 129. Clearside Biomedical Latest Developments Table 130. Graybug Vision Inc Basic Information, Ocular Drug Delivery Manufacturing Base, Sales Area and Its Competitors Table 131. Graybug Vision Inc Ocular Drug Delivery Product Offered Table 132. Graybug Vision Inc Ocular Drug Delivery Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022) Table 133. Graybug Vision Inc Main Business Table 134. Graybug Vision Inc Latest Developments Table 135. Taiwan Liposome Company Basic Information, Ocular Drug Delivery Manufacturing Base, Sales Area and Its Competitors Table 136. Taiwan Liposome Company Ocular Drug Delivery Product Offered Table 137. Taiwan Liposome Company Ocular Drug Delivery Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022) Table 138. Taiwan Liposome Company Main Business Table 139. Taiwan Liposome Company Latest Developments Table 140. Santen Pharmaceutical Basic Information, Ocular Drug Delivery Manufacturing Base, Sales Area and Its Competitors Table 141. Santen Pharmaceutical Ocular Drug Delivery Product Offered Table 142. Santen Pharmaceutical Ocular Drug Delivery Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022) Table 143. Santen Pharmaceutical Main Business Table 144. Santen Pharmaceutical Latest Developments List of Figures Figure 1. Picture of Ocular Drug Delivery Figure 2. Ocular Drug Delivery Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Ocular Drug Delivery Sales Growth Rate 2017-2028 (K Doses) Figure 7. Global Ocular Drug Delivery Revenue Growth Rate 2017-2028 ($ Millions) Figure 8. Ocular Drug Delivery Sales by Region (2021 & 2028) & ($ millions) Figure 9. Product Picture of Ocular Insert Figure 10. Product Picture of Iontophoresis Figure 11. Product Picture of Intraocular Implants Figure 12. Product Picture of In Situ Gel & Punctal Plugs Figure 13. Product Picture of Others Figure 14. Global Ocular Drug Delivery Sales Market Share by Type in 2021 Figure 15. Global Ocular Drug Delivery Revenue Market Share by Type (2017-2022) Figure 16. Ocular Drug Delivery Consumed in Hospitals Figure 17. Global Ocular Drug Delivery Market: Hospitals (2017-2022) & (K Doses) Figure 18. Ocular Drug Delivery Consumed in Ambulatory Surgical Centers Figure 19. Global Ocular Drug Delivery Market: Ambulatory Surgical Centers (2017-2022) & (K Doses) Figure 20. Ocular Drug Delivery Consumed in Ophthalmic Clinics Figure 21. Global Ocular Drug Delivery Market: Ophthalmic Clinics (2017-2022) & (K Doses) Figure 22. Ocular Drug Delivery Consumed in Homecare Settings Figure 23. Global Ocular Drug Delivery Market: Homecare Settings (2017-2022) & (K Doses) Figure 24. Global Ocular Drug Delivery Sales Market Share by Application (2017-2022) Figure 25. Global Ocular Drug Delivery Revenue Market Share by Application in 2021 Figure 26. Ocular Drug Delivery Revenue Market by Company in 2021 ($ Million) Figure 27. Global Ocular Drug Delivery Revenue Market Share by Company in 2021 Figure 28. Global Ocular Drug Delivery Sales Market Share by Geographic Region (2017-2022) Figure 29. Global Ocular Drug Delivery Revenue Market Share by Geographic Region in 2021 Figure 30. Global Ocular Drug Delivery Sales Market Share by Region (2017-2022) Figure 31. Global Ocular Drug Delivery Revenue Market Share by Country/Region in 2021 Figure 32. Americas Ocular Drug Delivery Sales 2017-2022 (K Doses) Figure 33. Americas Ocular Drug Delivery Revenue 2017-2022 ($ Millions) Figure 34. APAC Ocular Drug Delivery Sales 2017-2022 (K Doses) Figure 35. APAC Ocular Drug Delivery Revenue 2017-2022 ($ Millions) Figure 36. Europe Ocular Drug Delivery Sales 2017-2022 (K Doses) Figure 37. Europe Ocular Drug Delivery Revenue 2017-2022 ($ Millions) Figure 38. Middle East & Africa Ocular Drug Delivery Sales 2017-2022 (K Doses) Figure 39. Middle East & Africa Ocular Drug Delivery Revenue 2017-2022 ($ Millions) Figure 40. Americas Ocular Drug Delivery Sales Market Share by Country in 2021 Figure 41. Americas Ocular Drug Delivery Revenue Market Share by Country in 2021 Figure 42. United States Ocular Drug Delivery Revenue Growth 2017-2022 ($ Millions) Figure 43. Canada Ocular Drug Delivery Revenue Growth 2017-2022 ($ Millions) Figure 44. Mexico Ocular Drug Delivery Revenue Growth 2017-2022 ($ Millions) Figure 45. Brazil Ocular Drug Delivery Revenue Growth 2017-2022 ($ Millions) Figure 46. APAC Ocular Drug Delivery Sales Market Share by Region in 2021 Figure 47. APAC Ocular Drug Delivery Revenue Market Share by Regions in 2021 Figure 48. China Ocular Drug Delivery Revenue Growth 2017-2022 ($ Millions) Figure 49. Japan Ocular Drug Delivery Revenue Growth 2017-2022 ($ Millions) Figure 50. South Korea Ocular Drug Delivery Revenue Growth 2017-2022 ($ Millions) Figure 51. Southeast Asia Ocular Drug Delivery Revenue Growth 2017-2022 ($ Millions) Figure 52. India Ocular Drug Delivery Revenue Growth 2017-2022 ($ Millions) Figure 53. Australia Ocular Drug Delivery Revenue Growth 2017-2022 ($ Millions) Figure 54. Europe Ocular Drug Delivery Sales Market Share by Country in 2021 Figure 55. Europe Ocular Drug Delivery Revenue Market Share by Country in 2021 Figure 56. Germany Ocular Drug Delivery Revenue Growth 2017-2022 ($ Millions) Figure 57. France Ocular Drug Delivery Revenue Growth 2017-2022 ($ Millions) Figure 58. UK Ocular Drug Delivery Revenue Growth 2017-2022 ($ Millions) Figure 59. Italy Ocular Drug Delivery Revenue Growth 2017-2022 ($ Millions) Figure 60. Russia Ocular Drug Delivery Revenue Growth 2017-2022 ($ Millions) Figure 61. Middle East & Africa Ocular Drug Delivery Sales Market Share by Country in 2021 Figure 62. Middle East & Africa Ocular Drug Delivery Revenue Market Share by Country in 2021 Figure 63. Egypt Ocular Drug Delivery Revenue Growth 2017-2022 ($ Millions) Figure 64. South Africa Ocular Drug Delivery Revenue Growth 2017-2022 ($ Millions) Figure 65. Israel Ocular Drug Delivery Revenue Growth 2017-2022 ($ Millions) Figure 66. Turkey Ocular Drug Delivery Revenue Growth 2017-2022 ($ Millions) Figure 67. GCC Country Ocular Drug Delivery Revenue Growth 2017-2022 ($ Millions) Figure 68. Manufacturing Cost Structure Analysis of Ocular Drug Delivery in 2021 Figure 69. Manufacturing Process Analysis of Ocular Drug Delivery Figure 70. Industry Chain Structure of Ocular Drug Delivery Figure 71. Channels of Distribution Figure 72. Distributors Profiles
OCULAR THERAPEUTIX, INC Alimera Sciences Allergan, Plc EyeGate Pharma Valeant Pharmaceuticals International, Inc Envisia Therapeutics Clearside Biomedical Graybug Vision Inc Taiwan Liposome Company Santen Pharmaceutical
LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Primary Source
Players/Suppliers
Industry Experts
Distributors/Traders
Opinion Leaders
Front-line Staff
Marketing Executives
Secondary Source
Journals and Periodicals
Government Bodies
Annual Reports
Presentations
Paid Databases
LPI Internal Repository
Data Synthesis
Information Gathering
Collation of Data
Estimation of Key Figures
Analysis of Derived Insights
Data Validation
Triangulation with Data Models
Reference Against Proprietary
Databases
Corroboration with Industry Experts
Qualitative Analysis
Market drivers
Market challenges
Market trends
Five forces analysis
Qualitative Analysis
Market size and forecast
Market segmentation
Geographical insights
Competitive landscape